Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 10:21:40 UTC |
---|
Update Date | 2021-09-26 23:05:04 UTC |
---|
HMDB ID | HMDB0252469 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Fostamatinib |
---|
Description | Fostamatinib, also known as R 788 compound or tavalisse, belongs to the class of organic compounds known as methoxyanilines. These are organic compound containing an aniline group substituted at one or more positions by a methoxy group. Based on a literature review a significant number of articles have been published on Fostamatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Fostamatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Fostamatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29) |
---|
Synonyms | Value | Source |
---|
R 788 Compound | MeSH | R788 Compound | MeSH | Tavalisse | MeSH | R788 FREE acid | ChEMBL | R-788R-935788R935788 FREE acid | ChEMBL | {[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-2H,3H,4H,5H,6H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonate | Generator |
|
---|
Chemical Formula | C23H26FN6O9P |
---|
Average Molecular Weight | 580.4595 |
---|
Monoisotopic Molecular Weight | 580.148291177 |
---|
IUPAC Name | {[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-2H,3H,4H,5H,6H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonic acid |
---|
Traditional Name | [6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-5H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxyphosphonic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |
---|
InChI Identifier | InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29) |
---|
InChI Key | GKDRMWXFWHEQQT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as methoxyanilines. These are organic compound containing an aniline group substituted at one or more positions by a methoxy group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Aniline and substituted anilines |
---|
Direct Parent | Methoxyanilines |
---|
Alternative Parents | |
---|
Substituents | - Methoxyaniline
- Anisole
- Phenol ether
- Methoxybenzene
- Phenoxy compound
- Halopyrimidine
- Aminopyridine
- Aminopyrimidine
- Monoalkyl phosphate
- Alkyl aryl ether
- Organic phosphoric acid derivative
- Aryl halide
- Imidolactam
- Alkyl phosphate
- Pyrimidine
- Pyridine
- Phosphoric acid ester
- Aryl fluoride
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Lactam
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Ether
- Oxacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Organohalogen compound
- Organofluoride
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Fostamatinib,1TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4227.0 | Semi standard non polar | 33892256 | Fostamatinib,1TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4278.0 | Standard non polar | 33892256 | Fostamatinib,1TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 6778.2 | Standard polar | 33892256 | Fostamatinib,1TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4119.3 | Semi standard non polar | 33892256 | Fostamatinib,1TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4312.9 | Standard non polar | 33892256 | Fostamatinib,1TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 7082.2 | Standard polar | 33892256 | Fostamatinib,1TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4253.4 | Semi standard non polar | 33892256 | Fostamatinib,1TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4282.2 | Standard non polar | 33892256 | Fostamatinib,1TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 7252.1 | Standard polar | 33892256 | Fostamatinib,2TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4192.4 | Semi standard non polar | 33892256 | Fostamatinib,2TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4239.7 | Standard non polar | 33892256 | Fostamatinib,2TMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 6166.2 | Standard polar | 33892256 | Fostamatinib,2TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4107.2 | Semi standard non polar | 33892256 | Fostamatinib,2TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4171.8 | Standard non polar | 33892256 | Fostamatinib,2TMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 6286.4 | Standard polar | 33892256 | Fostamatinib,2TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4253.5 | Semi standard non polar | 33892256 | Fostamatinib,2TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4160.4 | Standard non polar | 33892256 | Fostamatinib,2TMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 6427.1 | Standard polar | 33892256 | Fostamatinib,2TMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4148.4 | Semi standard non polar | 33892256 | Fostamatinib,2TMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4208.7 | Standard non polar | 33892256 | Fostamatinib,2TMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 6625.3 | Standard polar | 33892256 | Fostamatinib,3TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4109.5 | Semi standard non polar | 33892256 | Fostamatinib,3TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4090.7 | Standard non polar | 33892256 | Fostamatinib,3TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 5716.6 | Standard polar | 33892256 | Fostamatinib,3TMS,isomer #2 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4232.1 | Semi standard non polar | 33892256 | Fostamatinib,3TMS,isomer #2 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 4093.9 | Standard non polar | 33892256 | Fostamatinib,3TMS,isomer #2 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC | 5855.0 | Standard polar | 33892256 | Fostamatinib,3TMS,isomer #3 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4150.1 | Semi standard non polar | 33892256 | Fostamatinib,3TMS,isomer #3 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4045.4 | Standard non polar | 33892256 | Fostamatinib,3TMS,isomer #3 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 5906.0 | Standard polar | 33892256 | Fostamatinib,4TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 4153.9 | Semi standard non polar | 33892256 | Fostamatinib,4TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 3954.5 | Standard non polar | 33892256 | Fostamatinib,4TMS,isomer #1 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC | 5375.7 | Standard polar | 33892256 | Fostamatinib,1TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4409.1 | Semi standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4490.4 | Standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 6830.7 | Standard polar | 33892256 | Fostamatinib,1TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4299.5 | Semi standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4501.8 | Standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 6966.9 | Standard polar | 33892256 | Fostamatinib,1TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 4432.9 | Semi standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 4495.9 | Standard non polar | 33892256 | Fostamatinib,1TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 7088.9 | Standard polar | 33892256 | Fostamatinib,2TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4518.5 | Semi standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 4582.2 | Standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #1 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC | 6285.7 | Standard polar | 33892256 | Fostamatinib,2TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4433.5 | Semi standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4509.7 | Standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #2 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 6260.2 | Standard polar | 33892256 | Fostamatinib,2TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 4593.7 | Semi standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 4530.5 | Standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #3 | COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC | 6374.7 | Standard polar | 33892256 | Fostamatinib,2TBDMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4504.3 | Semi standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4516.6 | Standard non polar | 33892256 | Fostamatinib,2TBDMS,isomer #4 | COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 6419.2 | Standard polar | 33892256 |
| Show more...
---|